DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leukine (Sargramostim) - Current Clinical Trials

 
 



Leukine Related Clinical Trials

Study of the Safety & Efficacy of Leukine´┐Ż in the Treatment of Alzheimer's Disease [Recruiting]

Leukine (Sargramostim) for Parkinson's Disease [Recruiting]

Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Terminated]

Randomized Phase III Trial of Leukine« vs Neupogen« in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [Terminated]

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma [Recruiting]

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Active, not recruiting]

Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery [Not yet recruiting]

FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia [Completed]

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma [Not yet recruiting]

Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia [Not yet recruiting]

A Safety/Tolerability and Pharmakokinetic Study of Sargramostim Administrated in the Gingiva [Completed]

Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Withdrawn]

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC [Terminated]

Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia [Active, not recruiting]

Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease [Terminated]

Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP) [Completed]

Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma [Completed]

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma [Completed]

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [Completed]

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Recurrent or Refractory Brain Tumors [Recruiting]

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent [Recruiting]

Open-label Trial of Leukine in Active Crohn's Disease [Terminated]

Sargramostim After Cryotherapy in Treating Patients With Prostate Cancer [Not yet recruiting]

Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma [Completed]

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia [Terminated]

Sargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced Melanoma [Completed]

Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP) [Enrolling by invitation]

RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure [Recruiting]

GM-CSF to Decrease ICU Acquired Infections [Not yet recruiting]

Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With Sargramostim [Terminated]

Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma [Active, not recruiting]

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma [Active, not recruiting]

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Completed]

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis [Not yet recruiting]

SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy [Not yet recruiting]

Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer [Terminated]

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease [Completed]

Sargramostim for Myeloid Dendritic Cell Deficiency [Completed]

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma [Active, not recruiting]

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Active, not recruiting]

Study of Sargramostim in Moderately to Severely Active Crohn's Disease [Terminated]

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere [Completed]

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease [Terminated]

Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [Active, not recruiting]

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [Completed]

Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [Terminated]

Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma [Active, not recruiting]

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Active, not recruiting]

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma [Active, not recruiting]

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma [Completed]

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [Completed]

The Effect of GCSF in the Treatment of ALS Patients [Completed]

Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC [Completed]

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab [Terminated]

GM-CSF in Treating Patients With Relapsed Prostate Cancer [Completed]

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma [Completed]

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine [Completed]

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [Completed]

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Completed]

High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) [Completed]

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy [Terminated]

A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS [Recruiting]

ATG-GCSF in New Onset Type 1 Diabetes [Recruiting]

Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD) [Recruiting]

Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Completed]

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung [Completed]

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Completed]

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma [Completed]

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [Completed]

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia [Completed]

Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Terminated]

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Terminated]

Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [Active, not recruiting]

A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF [Terminated]

Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma [Completed]

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Completed]

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [Withdrawn]

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer [Completed]

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer [Recruiting]

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients [Completed]

Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease [Completed]

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [Completed]

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa [Completed]

Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease [Active, not recruiting]

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) [Completed]

HER2-Peptide Vaccination of Patients With Solid Tumors [Recruiting]

Herceptin and GM-CSF for Metastatic Breast Cancer [Completed]

A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients [Terminated]

Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer [Terminated]

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma [Recruiting]

Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke [Completed]

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma [Suspended]

Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers [Completed]

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017